Molecular medicine and medical genetics are at the forefront of new and emerging health technologies. With these new techniques and discoveries come new challenges for the law, especially on the privacy front.
Earlier this year, I referenced Bills S-201 and 127 as legislative examples of society attempting to prevent the misuse of genetic information. In particular, there is a concern that incomplete knowledge or understanding of genetic predispositions, and still evolving understandings of how multiple genomes interact with each other, could result in logically skewed and flawed conclusions about employees or the insured, and result in a form of unwarranted . . . [more]